Skip to main content
Clinical Trials/ACTRN12609000619246
ACTRN12609000619246
Terminated
N/A

For adults with sudden sensorineural hearing loss, with or without tinnitus, and with an onset within the past 14 days, does the application of hyperbaric oxygen therapy, in addition to the standard therapy of oral steriods, result in an improvement in hearing, tinnitus or quality of life?

Michael Bennett0 sites225 target enrollmentJuly 27, 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Michael Bennett
Enrollment
225
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Michael Bennett

Eligibility Criteria

Inclusion Criteria

  • All adult patients (\>18 yrs) presenting with idiopathic sudden sensorineural hearing loss (ISSHL), with or without tinnitus and where the first hyperbaric session can be administered within 14 days of the onset of symptoms. Diagnosis will exclude other causes of sudden hearing loss historically (e.g. Menieur’s disease, barotrauma, noise\-induced hearing loss, ototoxic drugs) and by a magnetic resonance image (MRI) of the affected side to exclude an acoustic neuroma or other tumour.

Exclusion Criteria

  • Patient refusal (HBOT will not be offered to those who refuse to participate),
  • Contraindications to HBOT including inability to equalise the middle ear or respiratory sinuses, claustrophobia, pneumothorax, previous bleomycin administration or severe respiratory disease with carbon dioxide retention, presence of hearing decrement (documented) for greater than two weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials